Is it reasonable to use a lower DOAC dose in some patients with VTE? NO
Crossref DOI link: https://doi.org/10.1007/s11739-017-1695-8
Published Online: 2017-06-27
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dentali, Francesco
Fantoni, Chiara
License valid from 2017-06-27